DEBT CONVERSION AGREEMENTDebt Conversion Agreement • November 17th, 2006 • Fermavir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Debt Conversion Agreement made as of this 15th day of November, 2006 between FermaVir Pharmaceuticals, Inc., a Florida corporation (the “Company”) having a principal place of business at 420 Lexington Avenue, Suite 445, New York, NY 10170 and the parties who have executed this agreement (individually a “Creditor” and collectively the “Creditors”).
